Financial Advisory Service, Inc. Amgen Inc Transaction History

Financial Advisory Service, Inc.

$1.07 Billion
Q1 2024

A detailed history of Financial Advisory Service, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Financial Advisory Service, Inc. holds 7,360 shares of AMGN stock, worth $2.3 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

7,360

Previous 7,305 0.75%

Holding current value

$2.3 Million

Previous $2.1 Million 0.52%

% of portfolio

0.19%

Previous 0.21%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	BUY	$268.87 - $324.56 $14,787 - $17,850	55 Added 0.75%	7,360 $2.09 Million
Q4 2023 Jan 23, 2024	BUY	$255.7 - $288.46 $1.32 Million - $1.49 Million	5,162 Added 240.88%	7,305 $2.1 Million
Q3 2023 Oct 23, 2023	BUY	$218.65 - $271.46 $468,566 - $581,738	2,143 New	2,143 $575,000
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $3,386 - $4,128	15 Added 0.71%	2,120 $512,000
Q4 2022 Feb 01, 2023	SELL	$229.03 - $291.01 $92,299 - $117,277	-403 Reduced 16.07%	2,105 $552,000

Q3 2022 Oct 20, 2022	BUY	$224.46 - $253.15 $42,422 - $47,845	189 Added 8.15%	2,508 $565,000
Q2 2022 Aug 02, 2022	BUY	$230.71 - $256.74 $94,821 - $105,520	411 Added 21.54%	2,319 $564,000
Q1 2022 May 04, 2022	BUY	$219.27 - $242.57 $14,471 - $16,009	66 Added 3.58%	1,908 $461,000
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $16,705 - $19,118	-84 Reduced 4.36%	1,842 $414,000
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $9,552 - $11,191	-45 Reduced 2.28%	1,926 $410,000
Q2 2021 Jul 29, 2021	BUY	$233.58 - $259.14 $934 - $1,036	4 Added 0.2%	1,971 $481,000
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $7,766 - $9,051	35 Added 1.81%	1,967 $489,000
Q4 2020 Feb 10, 2021	BUY	$216.38 - $257.67 $3,678 - $4,380	17 Added 0.89%	1,932 $444,000
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $49,511 - $55,060	211 Added 12.38%	1,915 $487,000
Q2 2020 Jul 21, 2020	SELL	$197.81 - $242.74 $6,923 - $8,495	-35 Reduced 2.01%	1,704 $402,000
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $69,615 - $92,329	382 Added 28.15%	1,739 $353,000
Q4 2019 Jan 31, 2020	SELL	$189.21 - $243.2 $42,950 - $55,206	-227 Reduced 14.33%	1,357 $327,000
Q3 2019 Nov 06, 2019	SELL	$174.11 - $208.62 $348 - $417	-2 Reduced 0.13%	1,584 $307,000
Q2 2019 Jul 25, 2019	SELL	$166.7 - $195.41 $10,335 - $12,115	-62 Reduced 3.76%	1,586 $292,000
Q1 2019 May 13, 2019	BUY	$180.87 - $203.88 $3,436 - $3,873	19 Added 1.17%	1,648 $313,000
Q4 2018 Feb 08, 2019	SELL	$178.4 - $208.25 $6,600 - $7,705	-37 Reduced 2.22%	1,629 $317,000
Q3 2018 Nov 05, 2018	BUY	$185.29 - $208.89 $7,782 - $8,773	42 Added 2.59%	1,666 $345,000
Q2 2018 Jul 26, 2018	SELL	$166.05 - $186.51 $418,446 - $470,005	-2,520 Reduced 60.81%	1,624 $300,000
Q1 2018 May 02, 2018	SELL	$169.43 - $198.0 $69,466 - $81,180	-410 Reduced 9.0%	4,144 $706,000
Q4 2017 Jan 29, 2018	SELL	$168.79 - $188.59 $407,627 - $455,444	-2,415 Reduced 34.65%	4,554 $792,000
Q3 2017 Oct 19, 2017	BUY	$167.29 - $191.0 $1.17 Million - $1.33 Million	6,969	6,969 $1.3 Million

Others Institutions Holding AMGN

# of Institutions

2,930

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $167B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Advisory Service, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Advisory Service, Inc. with notifications on news.

Account

Financial Advisory Service, Inc. Amgen Inc Transaction History